scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...9j1763O |
P356 | DOI | 10.1371/JOURNAL.PONE.0101763 |
P932 | PMC publication ID | 4103775 |
P698 | PubMed publication ID | 25036938 |
P5875 | ResearchGate publication ID | 264054906 |
P50 | author | Alessandro Stefani | Q56418196 |
Enrica Olivola | Q59564394 | ||
Paola Imbriani | Q59692808 | ||
Mario Alberto Ugo Stampanoni Bassi | Q85651614 | ||
Vincenza D'Angelo | Q38323218 | ||
Nicola B. Mercuri | Q42521269 | ||
P2093 | author name string | Marco Conti | |
Claudio Liguori | |||
Mariangela Pierantozzi | |||
P2860 | cites work | Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. | Q51160375 |
Depression and Parkinson's disease: possible role of serotonergic mechanisms | Q68988930 | ||
Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients | Q73065148 | ||
Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque | Q95823022 | ||
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease | Q34296780 | ||
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial | Q34619438 | ||
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease | Q34619565 | ||
Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? | Q35004662 | ||
Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD | Q37536347 | ||
The serotonergic system in Parkinson's disease | Q37924025 | ||
The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery. | Q37968025 | ||
Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease. | Q37973611 | ||
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD. | Q38012590 | ||
Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease | Q42287995 | ||
Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea | Q42489819 | ||
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures | Q42794711 | ||
Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study | Q42952850 | ||
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease. | Q43068453 | ||
5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA. | Q43675942 | ||
Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease. | Q43792598 | ||
Mirtazapine in L-dopa-induced dyskinesias | Q44536093 | ||
Positron emission tomography of striatal serotonin transporters in Parkinson disease | Q44585433 | ||
Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease | Q44888788 | ||
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. | Q48095855 | ||
100 years of Lewy pathology | Q48278741 | ||
Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. | Q48413069 | ||
Altered serotonin metabolism in depressed patients with parkinson's disease. | Q48680548 | ||
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. | Q48846598 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e101763 | |
P577 | publication date | 2014-07-18 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart | |
P478 | volume | 9 |
Q61813331 | An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression |
Q43122361 | Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson's Disease. |
Q46365963 | Cytotoxic and cytoprotective effects of tryptamine-4,5-dione on neuronal cells: a double-edged sword. |
Q38639708 | Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease. |
Q64859245 | Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction? |
Q96953378 | Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism |
Q39105633 | Peripheral blood gene expression profiles linked to monoamine metabolite levels in cerebrospinal fluid. |
Search more.